RIVAROXABAN

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 31722-496
  • Package NDC 31722-496-18
  • Package NDC 31722-496-60
  • Application number ANDA219332
  • SPL ID d1afd534-ca74-462d-9cbb-03e54547cd9a
  • SPL set ID 45f16f1b-e405-4aa6-bc8b-977d4864af3e
  • UNII 9NDF7JZ4M3
  • RxCUI 2059015

What the source publishes

Labeler
Camber Pharmaceuticals, Inc.
Active ingredients
RIVAROXABAN
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:31722-496_d1afd534-ca74-462d-9cbb-03e54547cd9a
{
  "name": "RIVAROXABAN",
  "splId": "d1afd534-ca74-462d-9cbb-03e54547cd9a",
  "labels": [
    {
      "setId": "45f16f1b-e405-4aa6-bc8b-977d4864af3e",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45f16f1b-e405-4aa6-bc8b-977d4864af3e",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45f16f1b-e405-4aa6-bc8b-977d4864af3e"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Camber Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "180 TABLET, FILM COATED in 1 BOTTLE (31722-496-18)",
      "package_ndc": "31722-496-18",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250520"
    },
    {
      "sample": false,
      "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-496-60)",
      "package_ndc": "31722-496-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250520"
    }
  ],
  "productId": "31722-496_d1afd534-ca74-462d-9cbb-03e54547cd9a",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "31722-496",
  "deaSchedule": null,
  "genericName": "RIVAROXABAN",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RIVAROXABAN",
      "strength": "2.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA219332",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250520",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175635",
      "N0000175637"
    ],
    "upc": [
      "0331722496186",
      "0331722496605"
    ],
    "unii": [
      "9NDF7JZ4M3"
    ],
    "rxcui": [
      "2059015"
    ],
    "spl_set_id": [
      "45f16f1b-e405-4aa6-bc8b-977d4864af3e"
    ],
    "pharm_class_epc": [
      "Factor Xa Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Factor Xa Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Camber Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:31722-496_d1afd534-ca74-462d-9cbb-03e54547cd9a"